These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38605534)

  • 21. Sports Medicine Considerations When Caring for the Transgender Athlete.
    McGovern MM; Lowenstein NA; Matzkin EG
    Arthrosc Sports Med Rehabil; 2023 Aug; 5(4):100736. PubMed ID: 37645385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial.
    Cortez S; Moog D; Lewis C; Williams K; Herrick C; Fields M; Gray T; Guo Z; Nicol G; Baranski T
    JMIR Res Protoc; 2023 Dec; 12():e53092. PubMed ID: 38133914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis.
    Turino Miranda K; Kalenga CZ; Saad N; Dumanski SM; Collister D; Rytz CL; Lorenzetti DL; Chang DH; McClurg C; Sola DY; Ahmed SB
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H861-H868. PubMed ID: 36053748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Navigating Human Immunodeficiency Virus and Primary Care Concerns Specific to the Transgender and Gender-Nonbinary Population.
    Lieber M; Hamill MM; Pham P; Pine E; Crank J; Shah M
    Open Forum Infect Dis; 2022 Apr; 9(4):ofac091. PubMed ID: 35355890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand.
    Ittiphisit S; Amponnavarat S; Manaboriboon N; Korpaisarn S
    Sex Med; 2022 Jun; 10(3):100513. PubMed ID: 35428019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of gender-affirming endocrine care for sports participation.
    Moreland E; Cheung AS; Hiam D; Nolan BJ; Landen S; Jacques M; Eynon N; Jones P
    Ther Adv Endocrinol Metab; 2023; 14():20420188231178373. PubMed ID: 37323162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review.
    Ferraro JJ; Reynolds A; Edoigiawerie S; Seu MY; Horen SR; Aminzada A; Hamidian Jahromi A
    World J Methodol; 2022 Nov; 12(6):465-475. PubMed ID: 36479311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.
    Green AE; DeChants JP; Price MN; Davis CK
    J Adolesc Health; 2022 Apr; 70(4):643-649. PubMed ID: 34920935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults.
    Iwamoto SJ; Defreyne J; Kaoutzanis C; Davies RD; Moreau KL; Rothman MS
    Ther Adv Endocrinol Metab; 2023; 14():20420188231166494. PubMed ID: 37113210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fit Transitioning: When Can Transgender Airmen Fitness Test in Their Affirmed Gender?
    Chiccarelli E; Aden J; Ahrendt D; Smalley J
    Mil Med; 2023 Jul; 188(7-8):e1588-e1595. PubMed ID: 36271916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.
    Aranda G; Halperin I; Gomez-Gil E; Hanzu FA; Seguí N; Guillamon A; Mora M
    Front Endocrinol (Lausanne); 2021; 12():718200. PubMed ID: 34659112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
    Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
    Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
    [No Abstract]   [Full Text] [Related]  

  • 34. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
    Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
    Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.
    Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
    Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
    Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment.
    Masumori N; Nakatsuka M
    Circ Rep; 2023 Apr; 5(4):105-113. PubMed ID: 37025940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopsychosocial Mechanisms Linking Gender Minority Stress to HIV Comorbidities Among Black and Latina Transgender Women (LITE Plus): Protocol for a Mixed Methods Longitudinal Study.
    Rich AJ; Williams J; Malik M; Wirtz A; Reisner S; DuBois LZ; Juster RP; Lesko CR; Davis N; Althoff KN; Cannon C; Mayer K; Elliott A; Poteat T
    JMIR Res Protoc; 2020 Apr; 9(4):e17076. PubMed ID: 32281542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonprescription Hormone Use Among Transgender Women - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020.
    Olansky E; Lee K; Handanagic S; Trujillo L; ;
    MMWR Suppl; 2024 Jan; 73(1):34-39. PubMed ID: 38261588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.